BG
ONCE

BlackRock Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

BlackRock Group’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.43M Buy
68,841
+16,974
+33% +$909K ﹤0.01% 1394
2016
Q3 		$3.12M Buy
51,867
+43,110
+492% +$2.48M ﹤0.01% 1343
2016
Q2 		$447K Buy
8,757
+3,914
+81% +$167K ﹤0.01% 2305
2016
Q1 		$143K Buy
4,843
+2,328
+93% +$73.4K ﹤0.01% 2665
2015
Q4 		$114K Sell
2,515
-90,617
-97% -$4.75M ﹤0.01% 2659
2015
Q3 		$3.89M Sell
93,132
-68,778
-42% -$3.59M ﹤0.01% 1188
2015
Q2 		$9.76M Sell
161,910
-94,233
-37% -$6.23M 0.01% 974
2015
Q1 		$19.9M Buy
+256,143
New +$14.8M 0.01% 810

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SMV
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Group's ONCE Position: Q4 2016 in Review

BlackRock Group increased its Spark Therapeutics, Inc. Common Stock (ONCE) stake by 33% in Q4 2016, buying an estimated $909K and bringing the position to 68,841 shares worth $3.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1394.

BlackRock Group first reported a position in ONCE in Q1 2015 and has held it in 8 quarters since. The position peaked at $19.9M in Q1 2015. 119 funds tracked by Wall St. Rank hold ONCE as of Q4 2016.

  • BlackRock Group held 68,841 shares of Spark Therapeutics, Inc. Common Stock worth $3.43M as of Q4 2016.
  • BlackRock Group bought 16,974 Spark Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $909K.
  • Spark Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1394 holding.
  • BlackRock Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and has held it in 8 quarters since.
  • BlackRock Group's Spark Therapeutics, Inc. Common Stock position peaked at $19.9M in Q1 2015.
  • 119 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.